Paper30458058
Fecal microbiota transplantation in cancer management: Current status and perspectives.
Chen D and 4 others. Int J Cancer, 2019. Cited by 258 papers, by iCite.
Cite this record
ConductScience Library. Fecal microbiota transplantation in cancer management: Current status and perspectives. Papers, record 30458058. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30458058
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fecal Microbiota Transplantation | Major topic |
| Feces | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Neoplasms | Major topic |
| Clostridioides difficile | |
| Clostridium Infections | |
| Dysbiosis | |
| Humans | |
| Microbiota | |
| Treatment Outcome |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 17JCYBJC24900 | Tianjin Research Program of Application Foundation and Advanced Technology of China | International | PubMed | |
| 81741075 | National Natural Science Foundation of China | International | PubMed | |
| 81570478 | National Natural Science Foundation of China | International | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05502913 | Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer | Background |
Source ClinicalTrials.gov
References138
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28126350 | Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice. | Gastroenterology | 2017 | https://conductscience.org/library/papers/28126350 | PubMed |
| 2 | 29665102 | Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant. | Hepatology | 2018 | https://conductscience.org/library/papers/29665102 | PubMed |
| 3 | 29183074 | Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial. | JAMA | 2017 | https://conductscience.org/library/papers/29183074 | PubMed |
| 4 | 29567829 | The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. | Cancer Discov | 2018 | https://conductscience.org/library/papers/29567829 | PubMed |
| 5 | 29798856 | Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. | Science | 2018 | https://conductscience.org/library/papers/29798856 | PubMed |
| 6 | 28045107 | Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer. | Nat Rev Microbiol | 2017 | https://conductscience.org/library/papers/28045107 | PubMed |
| 7 | 22908323 | MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. | J Exp Med | 2012 | https://conductscience.org/library/papers/22908323 | PubMed |
| 8 | 23954158 | Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. | Cell Host Microbe | 2013 | https://conductscience.org/library/papers/23954158 | PubMed |
| 9 | 28087657 | European consensus conference on faecal microbiota transplantation in clinical practice. | Gut | 2017 | https://conductscience.org/library/papers/28087657 | PubMed |
| 10 | 25305284 | The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. | Clin Infect Dis | 2015 | https://conductscience.org/library/papers/25305284 | PubMed |
| 11 | 29042691 | Gastric cancer: The gastric microbiota - bacterial diversity and implications. | Nat Rev Gastroenterol Hepatol | 2017 | https://conductscience.org/library/papers/29042691 | PubMed |
| 12 | 28823860 | Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice. | Gastroenterology | 2017 | https://conductscience.org/library/papers/28823860 | PubMed |
| 13 | 27231050 | Gut microbiota, metabolites and host immunity. | Nat Rev Immunol | 2016 | https://conductscience.org/library/papers/27231050 | PubMed |
| 14 | 23439232 | Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. | Am J Gastroenterol | 2013 | https://conductscience.org/library/papers/23439232 | PubMed |
| 15 | 28274998 | Faecal microbiota transplantation in clinical practice. | Gut | 2018 | https://conductscience.org/library/papers/28274998 | PubMed |
| 16 | 23121625 | Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient. | Transpl Infect Dis | 2012 | https://conductscience.org/library/papers/23121625 | PubMed |
| 17 | 29209314 | Probiotic Strain Lactobacillus casei BL23 Prevents Colitis-Associated Colorectal Cancer. | Front Immunol | 2017 | https://conductscience.org/library/papers/29209314 | PubMed |
| 18 | 26264455 | Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: clinical efficacy and bacterial viability data. | Aliment Pharmacol Ther | 2015 | https://conductscience.org/library/papers/26264455 | PubMed |
| 19 | 22197980 | Preoperative probiotics decrease postoperative infectious complications of colorectal cancer. | Am J Med Sci | 2012 | https://conductscience.org/library/papers/22197980 | PubMed |
| 20 | 29122905 | Healthy donor faecal transplant for corticosteroid non-responsive severe alcoholic hepatitis. | BMJ Case Rep | 2017 | https://conductscience.org/library/papers/29122905 | PubMed |
Cited by203
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 258 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942942 | Nutritional Modulation of the Microbiota-Gut-Brain Axis in Cancer-Related Fatigue: A Narrative Review of Mechanisms, Biomarkers, and Interventions. | Nutrients | 2026 | https://conductscience.org/library/papers/42942942 | PubMed |
| 42891339 | Microbiome-pancreatic cancer crosstalk: From tumor biology to therapeutic intervention. | IMetaOmics | 2026 | https://conductscience.org/library/papers/42891339 | PubMed |
| 42807681 | Gut microbiota-mediated chemotherapy resistance in colorectal cancer: mechanisms and precision interventions. | Front Oncol | 2026 | https://conductscience.org/library/papers/42807681 | PubMed |
| 42688259 | Exploring factors influencing university students' participation in fecal microbiota donation: a descriptive qualitative study. | Front Public Health | 2026 | https://conductscience.org/library/papers/42688259 | PubMed |
| 42576658 | Microbiome-Driven Mechanisms in Breast Cancer: Emerging Evidence From Gut Microbial Signatures to Therapeutic Response. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/42576658 | PubMed |
| 42513245 | Gut Microbiota in Colorectal Cancer: Mechanisms of Carcinogenesis, Biomarkers, and Therapeutic Perspectives. | J Clin Med | 2026 | https://conductscience.org/library/papers/42513245 | PubMed |
| 42435167 | Metabolism-Driven Modulation by the Human Microbiota: Implications for Cancer Therapy and Emerging Strategies. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42435167 | PubMed |
| 42397471 | Enriched environment inhibits melanoma by reshaping gut microbiota and enriching Parabacteroides distasonis. | Cell Oncol (Dordr) | 2026 | https://conductscience.org/library/papers/42397471 | PubMed |
| 42366393 | The gastrointestinal microbiome and constituent short-chain fatty acids: a narrative review of an underexplored axis in acute lymphoblastic leukemia. | Gut Pathog | 2026 | https://conductscience.org/library/papers/42366393 | PubMed |
| 42281763 | Clinical Guidelines for Fecal Microbiota Transplantation in Companion Animals. | Adv Small Anim Care | 2024 | https://conductscience.org/library/papers/42281763 | PubMed |
| 42255244 | Beyond the tumor: the role of the gut microbiome in triple-negative breast cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42255244 | PubMed |
| 42165639 | Gut Microbiota: A Potential Role in Modulating Carcinogenesis and Response to Anti-Cancer Therapies. | Cancer Rep (Hoboken) | 2026 | https://conductscience.org/library/papers/42165639 | PubMed |
| 42106361 | Instance-based transfer learning enables cross-cohort early detection of colorectal cancer. | NPJ Biofilms Microbiomes | 2026 | https://conductscience.org/library/papers/42106361 | PubMed |
| 42101707 | The role of gut microbiota in thyroid cancer: from pathogenesis to diagnosis and treatment. | J Endocrinol Invest | 2026 | https://conductscience.org/library/papers/42101707 | PubMed |
| 42029022 | Applying microbial ecology frameworks to microbial therapies for wildlife. | mSystems | 2026 | https://conductscience.org/library/papers/42029022 | PubMed |
| 41967083 | Immunotherapy with guts: a review of microbial therapeutic adjuncts for immunotherapy in solid tumors. | Oncologist | 2026 | https://conductscience.org/library/papers/41967083 | PubMed |
| 41966656 | Gut microbiome impact on systemic therapy outcomes in metastatic renal cell carcinoma: a systematic review. | World J Urol | 2026 | https://conductscience.org/library/papers/41966656 | PubMed |
| 41845908 | Microbiome Landscapes in Squamous Cell Carcinoma Tissue Microenvironments: A Comparative Analysis. | Immun Inflamm Dis | 2026 | https://conductscience.org/library/papers/41845908 | PubMed |
| 41816110 | The role of gut microbiota and its metabolites in preventing oncogenesis. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/41816110 | PubMed |
| 41809178 | Methodological insights into fecal microbiota transplantation: Dissecting key approaches for success. | World J Methodol | 2026 | https://conductscience.org/library/papers/41809178 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APC | 324 | PubTator's text mining | https://conductscience.org/library/genes/324 | NCBI Gene |
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| TLR4 | 7099 | PubTator's text mining | https://conductscience.org/library/genes/7099 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30458058
GET https://conductscience.org/api/papers/v1/30458058/references?page=2